CAMBRIDGE, Mass.--(BUSINESS WIRE)--Seven Bridges, the biomedical data analysis company, today announced that Michael Hultner, PhD, Chief Strategy Officer of Seven Bridges, will present on a panel addressing Software-Defined Science: Case Studies In Applied Data/Analytics at the Cowen and Company FutureHealth Conference in San Francisco on June 21, 2017 at 2:30 p.m. PT.
About Seven Bridges
Seven Bridges is the biomedical data
analysis company accelerating breakthroughs in genomics research for
cancer, drug development and precision medicine. The scalable,
cloud-based Seven
Bridges Platform empowers rapid, collaborative analysis of millions
of genomes in concert with other forms of biomedical data. Thousands of
researchers in government, biotech, pharmaceutical and academic labs use
Seven Bridges, including three of the largest genomics projects in the
world: U.S. National Cancer Institute’s Cancer
Genomics Cloud pilot, the Million
Veteran Program, and Genomics England’s 100,000
Genomes Project. As the NIH’s only commercial Trusted
Partner, Seven Bridges authenticates and authorizes access to one of
the world’s largest cancer genomics dataset. Named one of the world's
smartest companies by MIT Technology Review, and a three-time
Bio-IT World Best of Show winner, Seven Bridges has offices in
Cambridge, Mass.; Belgrade; London; Istanbul; Ankara; and San Francisco.
